Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
365 studies found for:    Open Studies | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting BIONICS - Pharmacokinetics (PK) Trial
Condition: Heart Disease
Intervention: Device: BioNIR Ridaforolimus Eluting Coronary Stent
2 Recruiting Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
Condition: Congenital Heart Disease
Intervention: Drug: sulphur hexafluoride lipid-type A microspheres
3 Recruiting Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Conditions: Ventricular Premature Complexes;   Myocardial Ischemia
Intervention: Drug: ranolazine
4 Recruiting Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Conditions: Transient Ischemic Attack;   Stroke;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Warfarin
5 Recruiting A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
Condition: Ischemic Stroke
Interventions: Drug: BMS-986141;   Drug: Dilitazem
6 Recruiting Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Condition: Chronic Aphasia
Interventions: Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
7 Recruiting Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Conditions: Anemia;   Cardiovascular Disease
Interventions: Drug: EPO;   Drug: Feraheme
8 Recruiting AMPLATZER™ Amulet™ LAA Occluder Trial
Condition: Stroke
Interventions: Device: Amulet Left Atrial Appendage Occluder;   Device: WATCHMAN Left Atrial Appendage Closure
9 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
10 Recruiting AngioDefender Versus Brachial Artery Ultrasound Imaging
Condition: Cardiovascular Diseases
Interventions: Device: AngioDefender;   Device: Ultrasound
11 Recruiting Bococizumab HIV Evaluation (B-HIVE) Study
Conditions: Dyslipidemia;   Cardiovascular Disease
Interventions: Drug: Bococizumab;   Drug: Placebo
12 Recruiting Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Condition: Chronic Ischemic Stroke
Interventions: Biological: SB623 Implant (2.5M);   Biological: SB623 Implant (5.0M);   Procedure: Sham surgery
13 Recruiting Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Condition: Pediatric Heart Failure
Interventions: Drug: LCZ696;   Drug: Enalapril;   Drug: Placebo of LCZ696;   Drug: Placebo of Enalapril
14 Recruiting Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
Condition: Heart Failure
Interventions: Device: Jarvik 2000 VAS;   Device: HeartMate II
15 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
16 Recruiting Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Condition: Ischemic Attack, Transient
Interventions: Drug: Clopidogrel;   Drug: placebo
17 Not yet recruiting Study With Healthy Japanese and Non-Asian Participants With BMS-986231
Condition: Heart Decompensation, Acute
Interventions: Drug: BMS-986231;   Drug: BMS-986231 Placebo
18 Recruiting A Study of CLR325 in Chronic Stable Heart Failure Patients.
Condition: Chronic Stable Heart Failure
Interventions: Drug: CLR325;   Other: Placebo
19 Recruiting A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen
Condition: Acute Decompensated Heart Failure
Intervention: Drug: Furosemide Injection Solution 8mg/mL
20 Recruiting Sub-Q Versus IV Furosemide in Acute Heart Failure
Condition: Congestive Heart Failure
Interventions: Drug: Furosemide Injection Solution (SCP-101);   Drug: Furosemide Injection Solution, USP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.